Frontiers in Pharmacology | Cardiovascular and Smooth Muscle Pharmacology

Review

Published on 23 Jul 2025

Mechanisms of beneficial effects of DPP-4 inhibitors as a promising perspective for the prevention/treatment of the disruption of cardio-cerebrovascular homeostasis

in Cardiovascular and Smooth Muscle Pharmacology

Katarina Tomović Pavlović
Marko Anderluh
Andrija Šmelcerović

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1642333

284 views

Review

Accepted on 22 Jul 2025

Long-Acting Relaxin Analogues: a Novel Tool in Cardiology

in Cardiovascular and Smooth Muscle Pharmacology

Łukasz Wołowiec
Albert Jaśniak
Joanna Osiak
Daria Czaplińska
Agata Szymczak
Julia Anna Pęcherz Anna Pęcherz
Grzegorz Grześk

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1626469

Correction

Accepted on 22 Jul 2025

Correction: Alchemilla vulgaris modulates isoproterenol-induced cardiotoxicity: Interplay of oxidative stress, inflammation, autophagy, and apoptosis

in Cardiovascular and Smooth Muscle Pharmacology

Nuha Anajirih
Ahmed Abdeen
Ehab S. Taher
Afaf Abdelkader
Hoda A. Abd-Ellatieff
Mahmoud Saad Gewaily
Nashwa E. Ahmed
Rasha Hamed AlSerwi
Safwa M. Sorour
Heba M. Abdelkareem

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1650419

Case Report

Published on 18 Jul 2025

Case Report: Third-degree atrioventricular block and respiratory failure caused by clozapine poisoning

in Cardiovascular and Smooth Muscle Pharmacology

Qiaoxin Tian
Ruikai Shang
Yuru Liu
Hongyu Liu
Yingying Zheng
Xiangdong Jian

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1572578

339 views

Case Report

Published on 15 Jul 2025

A case report of ‘Two-Hit’ digenic mutations in PAH: role of PADN in management

in Cardiovascular and Smooth Muscle Pharmacology

Zai-qiang Zhang
Zhou-qiang Qin
Sheng-kui Zhu
Yu-hong Zuo
Jia-wang Ding

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1601777

325 views

Brief Research Report

Accepted on 14 Jul 2025

Comparative analysis of furosemide and torsemide efficacy in 24 hours of acute heart failure admission

in Cardiovascular and Smooth Muscle Pharmacology

Małgorzata Małek-Elikowska
Andrzej Szyszka
Julita Fedorowicz
Rafał Dankowski
Cyntia Szymańska
Artur Baszko

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1643077

111 views

Original Research

Accepted on 14 Jul 2025

The identification of adenylyl-cyclase modulators as potential receptors for 6-nitrodopamine in human induced pluripotent stem cell (hiPSCs)-derived cardiomyocytes and their relevance in the heart inotropism

in Cardiovascular and Smooth Muscle Pharmacology

Irene Cipollone
Vittoria Monaco
José Britto-Júnior
Antonio Tiago Lima
EDSON ANTUNES
Andre Sampaio Pupo
Ilaria Iacobucci
Flora Cozzolino
MARIA MONTI
Silvia Parisi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1597035

160 views

Original Research

Published on 14 Jul 2025

Fc-Elabela mitigates heart failure without liver and renal toxicity in mice

in Cardiovascular and Smooth Muscle Pharmacology

Huifen Zhou
Da-Wei Gong
Ling Chen
Hui Chen
Quan Wang
Mustajab Ullah
Saleem Ahmad
Ishtiaq Jeelani
Qingbin Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1555728

527 views

Original Research

Published on 14 Jul 2025

Gastrodin reduces myocardial ischemia/reperfusion injury via transgelin2/CNPase-mediated apoptosis regulation

in Cardiovascular and Smooth Muscle Pharmacology

Changyan Li
Peng Rao
Xiang Liu
Lin Yang
Yongliang Jiang
Gaosheng Yin
Shuangxiu Li
Ping Yang
Lin Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1604408

408 views

Case Report

Accepted on 11 Jul 2025

Micronized Purified Flavonoid Fraction [Daflon] induced bradycardia -a case report

in Cardiovascular and Smooth Muscle Pharmacology

Jhennyfer Aline Lima Rodrigues
Jonathas Pereira das Graças
Gledson de Oliveira Machado

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1612315

194 views

Case Report

Published on 11 Jul 2025

Low-molecular-weight heparin-induced thrombocytopenia with multisite embolism: successful management with argatroban and dabigatran – a case report and literature review

in Cardiovascular and Smooth Muscle Pharmacology

Huixin Zhao
Xiaowan Tang
Xitao Song

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1573840

396 views

Original Research

Published on 10 Jul 2025

Calycosin suppresses the activating effect of granulocyte-macrophage-colony-stimulating factor-producing T helper cells on macrophages in experimental atherosclerosis

in Cardiovascular and Smooth Muscle Pharmacology

Xiaofang Xiong
Wei Huang
Xuexue Yang
Xun Wang
Beibei Wu
Dongsheng Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1607349

371 views

Review

Published on 10 Jul 2025

Beyond the heart: a review exploring non-cardiovascular effects of vasoactive agents

in Cardiovascular and Smooth Muscle Pharmacology

Peng Lan
Lina Chen
Chen Zhang
Jun Ni
Peihao Yu
Jiancang Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1533437

311 views

Original Research

Published on 07 Jul 2025

Bitter taste receptor agonists induce vasorelaxation in porcine coronary arteries

in Cardiovascular and Smooth Muscle Pharmacology

Ching-Chung Tsai
Yi-Chen Li
Li-Ching Chang
Shih-Che Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1578913

494 views

Review

Published on 04 Jul 2025

Harnessing the therapeutic value of Tanshinone IIA: a breakthrough therapy in cardiovascular diseases

in Cardiovascular and Smooth Muscle Pharmacology

Lanxiang Du
Chengyan Guan
Hao Zhang
Haoyue Jia
Qiang Wan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1620152

522 views

Review

Published on 03 Jul 2025

Adenosine and adenosine receptors: a “double-edged sword” in cardiovascular system

in Cardiovascular and Smooth Muscle Pharmacology

Yongqi Qian
Yixuan Zheng
Liang Leng
Qingqing Liu
Xiaojuan Tian
Shilin Chen
Sanyin Zhang
Jiang Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1538680

814 views